1-2 of 2
Justin Watts, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

FT-2102, an IDH1m Inhibitor, in Combination with Azacitidine in Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Ayndrome (MDS): Results from a Phase 1 Study

Jorge E. Cortes, MD, Justin Watts, MD, Thomas Prebet, MD PhD, Gary J. Schiller, MD, Sangmin Lee, MD, Jay Yang, MD, Eunice S. Wang, MD, Shira Dinner, MD, Paul Brent Ferrell, Jr., MD, Will Donnellan, MD, Brian A. Jonas, MD PhD, Andrew H Wei, MBBS, PhD, Pau Montesinos, MD PhD, Montserrat Arnan Sangerman, MD, Patrick Kelly, MD, Ping Li, PhD, Jennifer Sweeney, Courtney Watson, Hesham Mohamed, MD, Maria R. Baer, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1452.
https://doi.org/10.1182/blood-2018-99-114126
Published: 2018
Journal Articles

Phase 1 Study of the IDH1m Inhibitor FT-2102 As a Single Agent in Patients with IDH1 m Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

Justin Watts, MD, Maria R. Baer, MD, Jay Yang, MD, Shira Dinner, MD, Sangmin Lee, MD, Karen Seiter, MD, Thomas Prebet, MD PhD, Gary J. Schiller, MD, Paul Brent Ferrell, Jr., MD, Kim-Hien Dao, DO, PhD, Hagop M. Kantarjian, MD, Patrick Kelly, MD, Ping Li, PhD, Jennifer Sweeney, Courtney Watson, Hesham Mohamed, MD, Jorge E. Cortes, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1453.
https://doi.org/10.1182/blood-2018-99-114263
Published: 2018